| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $580.13M | - | |
| Dir | 2.83M | $468.86M | -669,596 | |
| CEO | 82.1K | $13.60M | - | |
| VP | 41.9K | $6.95M | - | |
| VP | 33.0K | $5.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $351.66 | $1,160,478.00 | -0.8% | |
| Sep 10, 2018 | Ronaghi Mostafa | Sr VP &CTO | Sale+OE | 10,000 | $347.07 | $3,470,708.66 | -2.1% | |
| Sep 7, 2018 | Epstein Robert S | Director | Sale+OE | 1,346 | $345.14 | $464,558.44 | -18.9% | |
| Sep 4, 2018 | Stapley Marc60 | EVP Strategy &Corp Developmt | Sell | 1,000 | $352.05 | $352,054.10 | -3.7% | |
| Sep 4, 2018 | Desouza Francis A | President And CEO | Sell | 2,100 | $353.66 | $742,686.00 | -1.4% | |
| Sep 4, 2018 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 1,091 | $354.18 | $386,410.38 | -8.9% | |
| Aug 10, 2018 | Ronaghi Mostafa | Sr VP &CTO | Sale+OE | 10,000 | $331.39 | $3,313,860.96 | -3.3% | |
| Aug 2, 2018 | Ostadan Omead81 | EVP Ops, Products, Strategy | Sell | 1,334 | $320.70 | $427,813.80 | -5.2% | |
| Aug 2, 2018 | Stapley Marc60 | EVP Strategy &Corp Developmt | Sell | 1,000 | $324.80 | $324,798.20 | -2.5% | |
| Aug 1, 2018 | Desouza Francis A | President And CEO | Sell | 2,100 | $327.41 | $687,555.00 | -0.5% |